Is Compounded Semaglutide Still Legal in 2026? What You Need to Know

If you’ve been following GLP-1 news lately, you’ve probably seen headlines about the FDA, compounding pharmacies, and telehealth companies. It’s a lot to sort through — and if you’re considering a provider-supervised weight management program, you deserve a straight answer.

Here’s what’s actually happening and what it means for you.

What Is Compounded Semaglutide?

Compounded semaglutide is a prescription medication prepared by a licensed compounding pharmacy. It contains the same active ingredient as brand-name GLP-1 medications but is not the same product as Ozempic, Wegovy, or any other FDA-approved finished drug. Compounded medications are legal under federal law when prepared by FDA-registered pharmacies and prescribed by licensed healthcare providers for individual patients.

Is Compounded Semaglutide Legal in 2026?

Yes — compounded semaglutide remains legal in 2026 under specific conditions. The FDA permits compounding when a drug appears on the shortage list or when a patient has a demonstrated medical need that cannot be met by a commercially available product. Licensed 503A and 503B pharmacies operating under FDA oversight may legally compound semaglutide for individual patients when prescribed by a licensed provider.

CoraDoc works exclusively with LegitScript-certified telehealth infrastructure and dispenses only through DIRX, an FDA-registered pharmacy. Every prescription is reviewed and issued by a licensed physician before any medication is dispensed.

What Did the FDA Actually Say?

Medical Care from $99/Month

Semaglutide and tirzepatide programs

Triple free promise
All 50 states
Licensed doctors

View All Programs →

Affirm. Klarna. Afterpay. HSA/FSA accepted

In early 2025, the FDA declared the semaglutide shortage resolved, which created uncertainty about whether compounding could continue. However, compounding pharmacies and telehealth providers have continued operating legally under 503A rules, which allow patient-specific compounding regardless of shortage status when medically appropriate.

The FDA has also signaled increased scrutiny of misleading advertising — specifically targeting companies making unsupported weight loss claims or misrepresenting compounded products as equivalent to brand-name drugs.

CoraDoc has never made those claims. Our compliance standards are built around LegitScript certification requirements, which include strict advertising guidelines, transparent pricing, and licensed provider oversight.

What Should You Look for in a Compounded GLP-1 Provider?

Not all telehealth providers operate the same way. Here’s what matters:

• LegitScript certification — verifies the platform meets pharmacy and telehealth compliance standards
• FDA-registered pharmacy — your medication should be dispensed by a licensed, inspected facility
• Licensed physician oversight — a real provider should review your health profile before prescribing
• Transparent pricing — no hidden fees, no surprise subscription charges
• Clear compliance language — any provider making specific weight loss guarantees or claiming their product is “the same as” a brand-name drug is operating outside FDA guidelines

CoraDoc meets all of these standards. Our providers review every patient individually and set realistic goals based on your personal health profile.

What Makes CoraDoc Different?

CoraDoc is a LegitScript-certified national GLP-1 telehealth platform operating in all 50 states. We offer compounded semaglutide and compounded tirzepatide programs on a one-time payment model — no subscriptions, no auto-renew, no hidden fees.

Every CoraDoc program includes:

• Free provider visit — your licensed physician reviews your health profile at no charge
• Free 2-day shipping — dispensed through DIRX pharmacy directly to your door
• Free supplies — syringes and supplies included

Your licensed provider will work with you to set realistic goals based on your individual health profile.

The Bottom Line

Compounded semaglutide is legal in 2026 when prescribed by a licensed provider and dispensed by an FDA-registered pharmacy. The regulatory environment is evolving, and it’s more important than ever to choose a provider that operates with full transparency and proper certification.

CoraDoc was built for exactly this moment — compliant, certified, and committed to putting patients first.

Compounded semaglutide and compounded tirzepatide are prescription medications dispensed only after individual review by a licensed healthcare provider. Not FDA-approved as finished drug products. Not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Individual results vary. For informational purposes only. Not medical advice.